Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PopS-HF: Pharmacological Optimization in Prevention in Heart Failure in Women
NCT07295522Phase 4Recruiting
- Sponsor
- Policlinico San Donato
- Start
- Mar 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in heart failure (HF) (2 arms), sponsored by Policlinico San Donato. Primary endpoint: Composite of all-cause mortality, heart failure (HF) readmission, or worsening HF at 12 months. Started Mar 2026; status: recruiting.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07295522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07295522.